Ticker
PBYICompany Name
PUMA BIOTECHNOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Inventory | Current Liabilities | Quick Ratio |
---|---|---|---|---|
6/30/2025 | $ 136.58M | $ 8.59M | $ 79.1M | 1.62 |
3/31/2025 | $ 132.51M | $ 8.75M | $ 86.66M | 1.43 |
12/31/2024 | $ 147.66M | $ 8.72M | $ 96.11M | 1.45 |
9/30/2024 | $ 156.82M | $ 2.67M | $ 110.4M | 1.4 |
6/30/2024 | $ 137.72M | $ 9.05M | $ 104.3M | 1.23 |
3/31/2024 | $ 143.03M | $ 7.1M | $ 98.19M | 1.38 |
12/31/2023 | $ 156.19M | $ 7.08M | $ 99.38M | 1.5 |
9/30/2023 | $ 125.35M | $ 5.68M | $ 67.36M | 1.78 |
6/30/2023 | $ 118.55M | $ 7.63M | $ 60.29M | 1.84 |
3/31/2023 | $ 111.75M | $ 3.89M | $ 48.19M | 2.24 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(AssetsC - Inventory) / LiabilitesC
(=) Quick Ratio
Quick Ratio for PUMA BIOTECHNOLOGY INC is calculated as follows: (AssetsC [ $ 159.8M ] - Inventory [ $ 3.14M ]) / LiabilitesC [ $ 118.2M ]
(=) Quick Ratio [ 1.33 ]
Minimum
Mar 31, 2021
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 3.12K |
---|---|
min | -0.73 |
max | 5.45 |
average | 1.55 |
median | 1.23 |
std | 1.17 |